Farm Comunitarios. 2021 Jul 02;13(3):17-24. doi: 10.33620/FC.2173-9218.(2021/Vol13).003.03

Home pharmaceutical care for frailty patients in Gipuzkoa

Aizpurua-Arruti X1, 2, Malet-Larrea A1, Oñatibia-Astibia A1, del-Pozo-Rodríguez A2, Goyenechea E1, Gastelurrutia MA1, 3
1. Colegio Oficial de Farmacéuticos de Gipuzkoa, Donostia/San Sebastián. 2. Facultad de Farmacia (Universidad del País Vasco). Grupo de Farmacocinética, Nanotecnología y Terapia génica (PharmaNanoGene), Vitoria-Gasteiz. 3. Grupo de Investigación de Atención Farmacéutica, Universidad de Granada.
Aizpurua-Arruti X, Malet-Larrea A, Oñatibia-Astibia A, del-Pozo-Rodríguez A, Goyenechea E, Gastelurrutia MA. Home pharmaceutical care for frailty patients in Gipuzkoa. Farm Comunitarios. 2021 Jul 02;13(3):17-24. doi: 10.33620/FC.2173-9218.(2021/Vol13).003.03
Abstract : 

Introduction: Home health care is one of the strategies promoted by administrations for patients with multiple pathologies, who live at home and who, due to their degree of disability or vulnerability, cannot go to health centers. This study consists of piloting home pharmaceutical care (HFC) by offering individualized responses to patients at home, within the multidisciplinary team for the care of frailty patients of the Hurkoa Foundation.

Material and methods: All pharmacies in the municipalities of Irún and Azkoitia were summoned to a training session. Patients included in the Hurkoa Foundation’s Comprehensive Fragility Care Plan who required help with medication management and agreed to include a pharmacist in the multidisciplinary care team, selected their community pharmacy. Pharmacists at these pharmacies conducted a review of the medicine cabinet (brown bag) along with the medication review.

Results: In the review of the medicine cabinet (brown bag), expired or unused medications were detected and between 2 and 3 medications were withdrawn from all patients. In the review of the medication, they detected at least one “PRM” in all the patients in the study. In the satisfaction evaluation, 100% of the patients reported a high degree of satisfaction with the program.

Discussion: The present study reinforces the importance of including the community pharmacist in the HFC multidisciplinary team, offering individualized responses to each patient, improving the management of their medication and thus achieving significant improvements in quality of life.

Editor: © SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. 
Copyright© SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. This article is available from url https://www.farmaceuticoscomunitarios.org/. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en

Share

-

Manual for authors

Journal Information